Learn more about how AMT-130 aims to "silence" the huntingtin gene.
This clinical trial tool will help you find Huntington's disease experiments currently taking place.
Learn about drugs that are currently in development or in clinical trials for HD
VX15 may have the potential to slow the progression of brain inflammation, which has been shown to impair thinking, movement, and behavior in HD animal models. VX15 has not been approved by the FDA; its potential benefits for HD are being investigated within the SIGNAL trial.
Laquinimod is an investigational drug being studied to see if it may have an effect on the symptoms of HD, including abnormal movements, memory problems, and emotional disorders.
SRX246 is an experimental treatment for symptoms of irritability in Huntington's disease.